Atlas Trials

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects

Clinical trial NCT02273544 · TERMINATED

Trial details

NCT number
NCT02273544
Sponsor
Boehringer Ingelheim
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2002-09-01
Primary completion
2002-10-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.